All lobbying filings
TODD STRATEGY GROUP
Lobbying for ASTRAZENECA PHARMACEUTICALS LP · ​Biopharmaceutical Company.
Filing
Registration - Amendment
Lobbying activity
2
340B Program. Home Infusion for Part B Products. Medicare Reimbursement for New Technologies. General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Multi-Cancer Early Detection.
340B Program. Home Infusion for Part B Products. Medicare Reimbursement for New Technologies. General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Multi-Cancer Early Detection.